J. Gakuru

Tuberculosis IRIS: Pathogenesis, Presentation, and Management across the Spectrum of Disease

F. Cresswell, N. Bahr, Victoria Poplin, 2020, Life.

Improving Technology to Diagnose Tuberculous Meningitis: Are We There Yet?

F. Cresswell, N. Bahr, J. Ellis, 2022, Frontiers in Neurology.

Pregnancy-Related Tuberculous Meningitis and Immune Reconstitution Inflammatory Syndrome: A Case Series and Systematic Review

D. Boulware, F. Cresswell, K. Pastick, 2022, Open forum infectious diseases.

Firearm Injuries at Selected Hospitals in Kenya

H. Saidi, V. Mutiso, J. Gakuru, 2010 .

Symptomatic Cryptococcal Meningitis with Negative Serum and Cerebrospinal Fluid Cryptococcal Antigen Tests

D. Meya, F. Bongomin, R. Kwizera, 2021, HIV/AIDS.

COVID-19 and the HIV care continuum in Uganda: minimising collateral damage

F. Cresswell, Darlisha A Williams, D. Meya, 2020, AAS Open Research.

Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial.

Takudzwa J Mtisi, S. Jaffar, D. Boulware, 2022, The Lancet. Global health.

Adherence of health workers to guidelines for screening and management of cryptococcal meningitis in Uganda

D. Boulware, D. Meya, A. Musubire, 2023, PloS one.

Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial.

D. Boulware, K. H. Hullsiek, P. Williamson, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cryptococcal meningitis

D. Boulware, M. Abassi, R. Rajasingham, 2023, Nature Reviews Disease Primers.

869. Oral Encochleated Amphotericin B for Cryptococcal Meningitis: a Phase II Randomized Trial

D. Boulware, K. H. Hullsiek, Darlisha A Williams, 2022, Open Forum Infectious Diseases.

Advancing Diagnosis and Treatment in People Living with HIV and Tuberculosis Meningitis

D. Boulware, F. Cresswell, S. Wasserman, 2023, Current HIV/AIDS reports.